Contact Us

TOURISM NEWS

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

Jan 14, 2025

SHANGHAI and NORTH CHICAGO,Ill.,Jan. 13,2025-- Simcere Zaiming,a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement

CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

Jan 14, 2025

SHANGHAI,Jan. 13,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

Jan 14, 2025

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.

Trillium Flow Technologies Successfully Completes Refinancing

Jan 14, 2025

STAMFORD,Conn.,Jan. 13,2025-- Trillium Flow Technologies ("Trillium"),a portfolio company of First Reserve,and a global designer,manufacturer,and aftermarket services provider of highly eng

ADP Research: Only 24% of Global Workers Are Confident They Have Skills for Career Advancement

Jan 14, 2025

Study examines the untapped potential of workers in the first of a series of studies comprising the refreshed "People at Work 2025" report,built on the ADP Research Global Workforce Survey

O-RAN ALLIANCE Announces Its New Board of Directors for the Term 2024-2026

Jan 14, 2025

O-RAN ALLIANCE Extended Board of Directors has been elected for the upcoming 2-year term Abdurazak Mudesir,Group CTO of Deutsche Telekom,was re-elected as Chair of the Board

1 ... 139 140 141 142 143 144 145 ... 351